MarketsStocksKABRADG
KA

Kabra Drugs Ltd

NSE: KABRADGBSE: 524322Healthcare
Download Research Report7-page PDF
21.58
-4.05%
NSE · auto-updates while market open
Mkt Cap
₹52 Cr
P / E
10.5
P / B
1.8
ROE
18.3%
52W High
₹35.52
52W Low
₹11.63
Key Metrics
Market Cap
₹52 Cr
P / E
10.54
P / B
1.77
EV / EBITDA
8.32
ROCE
20.9%
ROE
18.3%
Debt / Equity
0.01
Book Value
₹12.49
EPS
₹2.09
Div Yield
0.0%
Face Value
-
Promoter Holding
-
Revenue · ₹ Cr
0
FY22
0
FY24
1
FY25
93
FY26
Net Profit · ₹ Cr
5
0
-1
-1
FY22FY24FY25FY26
EPS · ₹ per share
₹2.1
₹-0.4
₹-1.7
FY22FY24FY26
Q1 2026 snapshot
Sales
₹36 Cr
Operating profit
-
OPM
-
Net profit
₹1 Cr
EPS
₹0.45
Scorecard · 7 axes
Quality
Strong
88/100
Valuation
Strong
10.5×
Growth
-
Profitability
Good
19.6%
Performance
Strong
+93.4%
Entry Point
Good
61%
Red Flags
Strong
0 flags
Shareholding Pattern
100.0%Public
Public100.0%
Quarterly Results · ₹ Cr
QuarterFY24 12QFY25 03QFY25 06QFY25 09QFY25 12QFY26 03Q
Revenue00.647.1719.9430.635.52
Net Profit-0.5370.394-0.51.8372.5661.064
NPM %-61.5%-7.0%9.2%8.4%3.0%
AlertPre-trade